Research graph
References from serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data. Local targets link to admitted publications; unresolved targets remain external evidence.
Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries
10.1111/tmi.12737 · 2016 · External reference
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data
10.1016/j.epidem.2024.100806 · 2024 · External reference
Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy
10.3390/pathogens11070732 · 2022 · External reference
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
10.1186/s12916-021-01982-x · 2021 · External reference
A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis
10.1086/505400 · 2006 · External reference
Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand
10.1016/j.eclinm.2021.101033 · 2021 · External reference
Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh
10.1371/journal.pntd.0005475 · 2017 · External reference
Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases
10.1371/journal.pntd.0009457 · 2021 · External reference
Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study
10.1017/s095026882300122x · 2023 · External reference
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust
10.12688/wellcomeopenres.17143.3 · 2022 · External reference
Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018-2019 influenza season
10.1111/irv.12805 · 2021 · External reference
Influenza infection rates, measurement errors and the interpretation of paired serology
10.1371/journal.ppat.1003061 · 2012 · External reference
Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections
10.1371/journal.pcbi.1004882 · 2016 · External reference
Inferring infection hazard in wildlife populations by linking data across individual and population scales
10.1111/ele.12732 · 2017 · External reference
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk
10.1038/s41586-018-0157-4 · 2018 · External reference
Reconstructing antibody dynamics to estimate the risk of influenza virus infection
10.1038/s41467-022-29310-8 · 2022 · External reference
Reversible jump Markov chain Monte Carlo computation and Bayesian model determination
10.1093/biomet/82.4.711 · 1995 · External reference
Markov Chain Monte Carlo Methods for Fitting Spatiotemporal Stochastic Models in Plant Epidemiology
10.1111/1467-9876.00061 · 1997 · External reference
Unresolved reference
2014 · External reference
Multivariate mixtures of normals with unknown number of components
10.1007/s11222-006-5338-6 · 2006 · External reference
On the Reversible Jump Markov Chain Monte Carlo (RJMCMC) Algorithm for Extreme Value Mixture Distribution as a Location-Scale Transformation of the Weibull Distribution
10.3390/app11167343 · 2021 · External reference
On Bayesian analysis of mixtures with an unknown number of components
10.1111/1467-9868.00095 · 1997 · External reference
Model choice using reversible jump Markov chain Monte Carlo
10.1111/j.1467-9574.2012.00516.x · 2012 · External reference
serosim: An R package for simulating serological data arising from vaccination, epidemiological and antibody kinetics processes
10.1371/journal.pcbi.1011384 · 2023 · External reference
An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver
2020 · External reference
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
1972 · External reference
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
10.1038/s41591-021-01377-8 · 2021 · External reference
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
10.1016/j.immuni.2024.01.017 · 2024 · External reference
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
10.1038/s41467-024-48098-3 · 2024 · External reference
Linking the seroresponse to infection to within-host heterogeneity in antibody production
10.1016/j.epidem.2016.04.001 · 2016 · External reference
10.1016/j.ebiom.2024.105319
10.1016/j.ebiom.2024.105319 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Convergence Tests for Transdimensional Markov Chains in Geoscience Imaging
10.1007/s11004-019-09811-x · 2019 · External reference
Estimation of the Continuous Ranked Probability Score with Limited Information and Applications to Ensemble Weather Forecasts
10.1007/s11004-017-9709-7 · 2017 · External reference
Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2
10.3390/microorganisms9061340 · 2021 · External reference
Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
10.3390/vaccines10081169 · 2022 · External reference
Unresolved reference
External reference
Unresolved reference
2025 · External reference
Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China
10.1371/journal.ppat.1002802 · 2012 · External reference
